INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$1.87 USD
-0.01 (-0.53%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $1.90 +0.03 (1.60%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
INBS 1.87 -0.01(-0.53%)
Will INBS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INBS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for INBS
Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
Intelligent Bio Solutions completes in-clinic portion of PK study
Intelligent Bio Solutions Advances in Regulatory Approval Process
Intelligent Bio Solutions expands presence in the UK retail sector